Literatur
- 1
Stamboulis E, Katsaros N, Koutsis G. et al .
Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating
polyradiculoneuropathy.
Muscle Nerve.
2006;
33
78-84
- 2
Noronha A B, Harper J R, Ilyas A A. et al .
Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein
of human melanoma cells.
J Neurochem.
1986;
47
1558-1565
- 3
Tsuchida T, Saxton R E, Morton D L. et al .
Gangliosides of human melanoma.
Cancer.
1989;
63
1166-1174
- 4
Saperstein D S, Katz J S, Amato A A. et al .
Clinical spectrum of chronic acquired demyelinating polyneuropathies.
Muscle Nerve.
2001;
24
311-324
- 5
Koller H, Kieseier B C, Jander S. et al .
Chronic inflammatory demyelinating polyneuropathy.
N Engl J Med.
2005;
352
1343-1356
- 6
Hughes R A, Donofrio P, Bril V. et al .
Intravenous immune globulin (10 % caprylate-chromatography purified) for the treatment
of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised
placebo-controlled trial.
Lancet Neurol.
2008;
7
136-144
- 7
Stangel M, Hartung H P, Gold R. et al .
[The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].
Nervenarzt.
2009;
80
678-687
- 8
Hughes R A, Bouche P, Cornblath D R. et al .
European Federation of Neurological Societies / Peripheral Nerve Society guideline
on management of chronic inflammatory demyelinating polyradiculoneuropathy: report
of a joint task force of the European Federation of Neurological Societies and the
Peripheral Nerve Society.
Eur J Neurol.
2006;
13
326-332
- 9
Bril V, Katzberg H, Donofrio P. et al .
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
Muscle Nerve.
2009;
39
448-455
- 10
Nobile-Orazio E.
Multifocal motor neuropathy.
J Neuroimmunol.
2001;
115
4-18
- 11
Nobile-Orazio E, Cappellari A, Priori A.
Multifocal motor neuropathy: current concepts and controversies.
Muscle Nerve.
2005;
31
663-680
- 12
Kaji R, Shibasaki H, Kimura J.
Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin
therapy.
Neurology.
1992;
42
506-509
- 13
Sumner A J.
Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy
with persistent conduction block.
Adv Neurol.
1991;
56
399-403
- 14
Lange D J, Trojaborg W, McDonald T D. et al .
Persistent and transient „conduction block” in motor neuron diseases.
Muscle Nerve.
1993;
16
896-903
- 15
Jaspert A, Claus D, Grehl H. et al .
Multifocal motor neuropathy: clinical and electrophysiological findings.
J Neurol.
1996;
243
684-692
- 16
Katz J S, Wolfe G I, Bryan W W. et al .
Electrophysiologic findings in multifocal motor neuropathy.
Neurology.
1997;
48
700-707
- 17
Cornblath D R, Sumner A J.
Conduction block in neuropathies with necrotizing vasculitis.
Muscle Nerve.
1991;
14
185-186
- 18
Van Es H W, Van den Berg L H, Franssen H. et al .
Magnetic resonance imaging of the brachial plexus in patients with multifocal motor
neuropathy.
Neurology.
1997;
48
1218-1224
- 19
Pestronk A, Cornblath D R, Ilyas A A. et al .
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.
Ann Neurol.
1988;
24
73-78
- 20
Sadiq S A, Thomas F P, Kilidireas K. et al .
The spectrum of neurologic disease associated with anti-GM1 antibodies.
Neurology.
1990;
40
1067-1072
- 21
Lamb N L, Patten B M.
Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and
neuropathies.
Muscle Nerve.
1991;
14
1021-1027
- 22
Van den Berg-Vos R M, Franssen H, Wokke J H. et al .
Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin
treatment.
Ann Neurol.
2000;
48
919-926
- 23
Taylor B V, Gross L, Windebank A J.
The sensitivity and specificity of anti-GM1 antibody testing.
Neurology.
1996;
47
951-955
- 24
Van den Berg L H, Lokhorst H, Wokke J H.
Pulsed high-dose dexamethasone is not effective in patients with multifocal motor
neuropathy.
Neurology.
1997;
48
1135
- 25
Lehmann H C, Hoffmann F R, Fusshoeller A. et al .
The clinical value of therapeutic plasma exchange in multifocal motor neuropathy.
J Neurol Sci.
2008;
271
34-39
- 26
Meucci N, Cappellari A, Barbieri S. et al .
Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal
motor neuropathy.
J Neurol Neurosurg Psychiatry.
1997;
63
765-769
- 27
van Schaik I N, Bouche P, Illa I. et al .
European Federation of Neurological Societies / Peripheral Nerve Society guideline
on management of multifocal motor neuropathy.
Eur J Neurol.
2006;
13
802-808
- 28
Honnorat J, Antoine J C.
Paraneoplastic neurological syndromes.
Orphanet J Rare Dis.
2007;
2
22
- 29
Graus F, Delattre J Y, Antoine J C. et al .
Recommended diagnostic criteria for paraneoplastic neurological syndromes.
J Neurol Neurosurg Psychiatry.
2004;
75
1135-1140
- 30
Camdessanche J P, Antoine J C, Honnorat J. et al .
Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical
and electrophysiological study of 20 patients.
Brain.
2002;
125
166-175
- 31
Antoine J C, Mosnier J F, Absi L. et al .
Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without
anti-onconeural antibodies.
J Neurol Neurosurg Psychiatry.
1999;
67
7-14
- 32
Keime-Guibert F, Graus F, Fleury A. et al .
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu,
anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.
J Neurol Neurosurg Psychiatry.
2000;
68
479-482
- 33 Izquierdo J RC, Kissel J T. Vasculitic neuropathies. San Diego; Med Link Corporation
2007
- 34
Said G.
Vasculitic neuropathy.
Curr Opin Neurol.
1999;
12
627-629
- 35
Nadeau S E.
Diagnostic approach to central and peripheral nervous system vasculitis.
Neurol Clin.
1997;
15
759-777
- 36
de Groot K, Gross W L, Hellmich B.
[Therapy of primary systemic vasculitis].
Internist (Berl).
2003;
44
1541-1548
- 37
de Groot K, Rasmussen N, Bacon P A. et al .
Randomized trial of cyclophosphamide versus methotrexate for induction of remission
in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis Rheum.
2005;
52
2461-2469
- 38 Gold R, Toyka K V. Immuntherapie neurologischer Krankheiten. Bremen; Uni-Med Verlag
AG 2007
- 39
Kissel J T, Mendell J R.
Vasculitic neuropathy.
Neurol Clin.
1992;
10
761-781
- 40
Collins M P, Periquet M I, Mendell J R. et al .
Nonsystemic vasculitic neuropathy: insights from a clinical cohort.
Neurology.
2003;
61
623-630
- 41
Collins M P, Periquet M I.
Non-systemic vasculitic neuropathy.
Curr Opin Neurol.
2004;
17
587-598
- 42
Meuth S G, Kleinschnitz C.
Multifocal motor neuropathy: update on clinical characteristics, pathophysiological
concepts and therapeutic options.
Eur.
Neurol;
63
193-204
- 43
European Federation of Neurological Societies / Peripheral Nerve Society Guideline
on management of multifocal motor neuropathy. Report of a joint task force of the
European Federation of Neurological Societies and the Peripheral Nerve Society.
J Peripher Nerv Syst.
2006;
11
1-8
Dr. M. Tschernatsch-Gerriets
Neurologische Klinik
Justus-Liebig-Universität
Am Steg 14
35385 Gießen
Email: marlene.tschernatsch@neuro.med.uni-giessen.de
